A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility

Carcinogenesis

Volumn 35, Issue 7, 2014, Pages

  Zhang, Ruyang ^a   Chu, Minjie ^a   Zhao, Yang ^a   Wu, Chen ^b   Guo, Huan ^c   Shi, Yongyong ^d   Dai, Juncheng ^a   Wei, Yongyue ^a   Jin, Guangfu ^a   Ma, Hongxia ^a   Dong, Jing ^a   Yi, Honggang ^a   Bai, Jianling ^a   Gong, Jianhang ^a   Sun, Chongqi ^a   Zhu, Meng ^a   Wu, Tangchun ^c   Hu, Zhibin ^a   Lin, Dongxin ^b   Shen, Hongbing ^a   Chen, Feng ^a   more..

^a NANJING MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gene environment interaction; GWAS; Lung cancer; Smoking; SNP

Indexed keywords

TOBACCO SMOKE;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAN CHINESE; HERITABILITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ALGORITHM; CHINA; COMPARATIVE STUDY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; PROGNOSIS; RISK FACTOR; TOBACCO; TOBACCO DEPENDENCE;

ALGORITHMS; CASE-CONTROL STUDIES; CHINA; FOLLOW-UP STUDIES; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SMOKING; TOBACCO; TOBACCO USE DISORDER;

EID: 84903989501     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu076     Document Type: Article

References (61)

1. Jemal, A., et al. (2011) Global cancer statistics. CA Cancer J Clin, 61, 69-90.
2. Zhang, H., et al. (2003) The impact of tobacco on lung health in China. Respirology, 8, 17-21.
3. Stavrides, J.C. (2006) Lung carcinogenesis: pivotal role of metals in tobacco smoke. Free Radic Biol Med, 41, 1017-30.
4. Doll, R., et al. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst, 66, 1191-308.
5. Spitz, M.R., et al. (1999) Genetic susceptibility to tobacco carcinogenesis. Cancer Invest, 17, 645-59.
6. Amos, C.I., et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet, 40, 616-22.
7. Hung, R.J., et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452, 633-7.
8. McKay, J.D., et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet, 40, 1404-6.
9. Wang, Y., et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet, 40, 1407-9.
10. Hu, Z., et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet, 43, 792-6.
11. Dong, J., et al. (2012) Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. Nat Genet, 44, 895-9.
12. Manolio, T.A., et al. (2009) Finding the missing heritability of complex diseases. Nature, 461, 747-53.
13. Moore, J.H., et al. (2009) Epistasis and its implications for personal genetics. Am J Hum Genet, 85, 309-20.
14. Maher, B. (2008) Personal genomes: The case of the missing heritability. Nature, 456, 18-21.
15. Zhou, W., et al. (2002) Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res, 62, 1377-81.
16. Ito, H., et al. (2004) Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis, 25, 1395-401.
17. Shah, P.P., et al. (2008) Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res, 639, 1-10.
18. Spitz, M.R., et al. (2008) The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst, 100, 1552-6.
19. Singh, A.P., et al. (2010) Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determining risk of squamous cell lung carcinoma in men. Cancer Biomark, 8, 351-9.
20. Lu, J., et al. (2011) The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations. Hum Mutat, 32, 1299-308.
21. Hsia, T.C., et al. (2011) Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients. Anticancer Res, 31, 3601-5.
22. Kiyohara, C., et al. (2011) Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese population. BMC Cancer, 11, 459.
23. Ihsan, R., et al. (2012) Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer. PLoS One, 6, e29431.
24. VanderWeele, T.J., et al. (2012) Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol, 175, 1013-20.
25. Huang, B., et al. (2012) Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern Chinese. Int J Cancer, 131, E744-58.
26. Zhang, Z., et al. (2012) Cigarette smoking strongly modifies the association of complement factor H variant and the risk of lung cancer. Cancer Epidemiol, 36, e111-5.
27. Cheng, Z., et al. (2012) hOGG1, p53 genes, and smoking interactions are associated with the development of lung cancer. Asian Pac J Cancer Prev, 13, 1803-8.
28. Feng, Z., et al. (2012) Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis. Mol Biol Rep, 39, 57-69.
29. Deng, Q., et al. (2013) Imputation-based association analyses identify new lung cancer susceptibility variants in CDK6 and SH3RF1 and their interactions with smoking in Chinese populations. Carcinogenesis.
30. Howie, B., et al. (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet, 44, 955-9.
31. Price, A.L., et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet, 38, 904-9.
32. Purcell, S., et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet, 81, 559-75.
33. Pruim, R.J., et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics, 26, 2336-7.
34. Barrett, J.C., et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-5.
35. Pencina, M.J., et al. (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med, 27, 157-72; discussion 207-12.
36. Johnson, A.D., et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics, 24, 2938-9.
37. Aschard, H., et al. (2012) Challenges and opportunities in genome-wide environmental interaction (GWEI) studies. Hum Genet, 131, 1591-613.
38. Modarressi, M.H., et al. (2000) Cloning, characterization, and mapping of the gene encoding the human G protein gamma 2 subunit. Biochem Biophys Res Commun, 272, 610-5.
39. Yajima, I., et al. (2012) Reduced GNG2 expression levels in mouse malignant melanomas and human melanoma cell lines. Am J Cancer Res, 2, 322-9.
40. Leung, T., et al. (2006) Zebrafish G protein gamma2 is required for VEGF signaling during angiogenesis. Blood, 108, 160-6.
41. Visser-Grieve, S., et al. (2012) Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway. Oncogene, 31, 1189-95.
42. Ungvari, I., et al. (2012) Evaluation of a partial genome screening of two asthma susceptibility regions using bayesian network based bayesian multilevel analysis of relevance. PLoS One, 7, e33573.
43. Hong, M.G., et al. (2012) Genome-wide and gene-based association implicates FRMD6 in Alzheimer disease. Hum Mutat, 33, 521-9.
44. Zeng, Q., et al. (2008) The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell, 13, 188-92.
45. Pan, D. (2010) The hippo signaling pathway in development and cancer. Dev Cell, 19, 491-505.
46. Angus, L., et al. (2012) Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. Oncogene, 31, 238-50.
47. Ulazzi, L., et al. (2007) Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer. Mol Cancer, 6, 17.
48. Renard, I., et al. (2010) Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples. Eur Urol, 58, 96-104.
49. Guerrero-Preston, R., et al. (2011) NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva. Cancer Prev Res (Phila), 4, 1061-72.
50. Geng, J., et al. (2012) Methylation status of NEUROG2 and NID2 improves the diagnosis of stage I NSCLC. Oncol Lett, 3, 901-906.
51. Kim, J.S., et al. (2004) Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis, 25, 2165-71.
52. Divine, K.K., et al. (2005) Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers. Int J Cancer, 114, 400-5.
53. Buro-Auriemma, L.J., et al. (2013) Cigarette smoking induces small airway epithelial epigenetic changes with corresponding modulation of gene expression. Hum Mol Genet, 22, 4726-38.
54. Springer, J., et al. (2004) SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. Biol Chem, 385, 649-53.
55. Samanta, D., et al. (2012) Smoking attenuates transforming growth factor-beta-mediated tumor suppression function through downregulation of Smad3 in lung cancer. Cancer Prev Res (Phila), 5, 453-63.
56. Samanta, D., et al. (2012) Long-term smoking mediated down-regulation of Smad3 induces resistance to carboplatin in non-small cell lung cancer. Neoplasia, 14, 644-55.
57. Hong, J.A., et al. (2005) Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res, 65, 7763-74.
58. Kang, Y., et al. (2007) Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells. Oncogene, 26, 4394-403.
59. Zajac-Kaye, M. (2001) Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer, 34 Suppl 2, S43-6.
60. Rapp, U.R., et al. (2009) MYC is a metastasis gene for non-small-cell lung cancer. PLoS One, 4, e6029.
61. Allen, T.D., et al. (2011) Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer. Cancer Res, 71, 2212-21.